Supply Chain Intelligence

Axsome Therapeutics, Inc. Supply Chain

AXSM supply chain intelligence for Axsome Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

AXSM ·Last updated 2026-07-29 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

4Suppliers
3Customers
3Debt Items
20Related Chains

Axsome Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
JAZZ Jazz Pharmaceuticals plc 90% Pursuant to the Purchase Agreement, the Company agreed to make non-refundable, non-creditable royalty payments to Jazz
JAZZ Jazz Pharmaceuticals plc 90% Reciprocal relationship from JAZZ graph: Reciprocal relationship from AXSM graph: Reciprocal relationship from JAZZ graph: Reciprocal relationship from AXSM graph: Pursuant to the Purchase Agreement,…
AERIAL AERIAL 85% At the Initial Closing, the Company assumed all of the commitments of Jazz to SK and Aerial.
IGC IGC Pharma, Inc. 72% Reciprocal relationship from IGC graph: Reciprocal relationship from AXSM graph: Reciprocal relationship from IGC graph: Reciprocal relationship from AXSM graph: Reciprocal relationship from IGC grap…

Axsome Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
PHARMANOVIA PHARMANOVIA 92% The Company also sells SUNOSI to Distributors in Canada and on a product supply basis to Pharmanovia.
IGC IGC Pharma, Inc. 72% Reciprocal relationship from IGC graph: ing growth of the Life Sciences segment. These investments will fuel the development and delivery of innovative products that drive positive patient and custom…
XENE Xenon Pharmaceuticals Inc. 72% Reciprocal relationship from XENE graph: Reciprocal relationship from AXSM graph: Reciprocal relationship from XENE graph: Reciprocal relationship from AXSM graph: Reciprocal relationship from XENE g…

Axsome Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
AXSM-DEBT-8014 Warrants outstanding: 56.8 90% xbrl warrant detail from xbrl 2026-03-31.
AXSM-DEBT Debt stack $219.9M 90% Market cache reports total debt of $219.9M.
AXSM-DEBT-8015 Xbrl Convertible 90% xbrl convertible detail from xbrl 2016-12-31.

Axsome Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Axsome Therapeutics, Inc..

Axsome Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
AXSM-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 418 tracked holders.

Axsome Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ALEC Alector, Inc. 100.00 2
ACIU AC Immune SA 100.00 2
ALNY Alnylam Pharmaceuticals, Inc. 100.00 2
VNDA Vanda Pharmaceuticals Inc. 100.00 2
DAWN Day One Biopharmaceuticals Inc 100.00 2
BYSI BeyondSpring Inc. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
CLYM Climb Bio, Inc. 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AKTS Aktis Oncology, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
DWTX Dogwood Therapeutics, Inc. 100.00 2
EDSA Edesa Biotech, Inc. 100.00 2
DFTX Definium Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
NVO Novo Nordisk A/S 100.00 2
FHTX Foghorn Therapeutics Inc. 100.00 2
ACRS Aclaris Therapeutics, Inc. 100.00 2
View AXSM supply chain intel →

Explore the full interactive supply chain map for Axsome Therapeutics, Inc..

Open AXSM supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map